It has been reported that CD133+ cells are the dominant cell population in primary non-small cell lung cancer and that these cells have greater tumorigenic potential in severe combined immunodeficient (SCID) mice and greater involvement in stemness, adhesion, and motility in comparison to their CD133- counterparts [11]. The gene discussed is PROM1; the disease is non-small cell lung carcinoma.